Pharmacologic treatment of anxiety disorders in children and adolescents

被引：0
|
作者：
Velosa, JF
Riddle, MA
机构：
[1] Johns Hopkins Med Inst, Dept Psychiat, Div Child & Adolescent Psychiat, Baltimore, MD 21287 USA
[2] Univ Alabama Birmingham, Dept Psychiat, Birmingham, AL USA
[3] Kennedy Krieger Inst, Baltimore, MD USA
来源：
CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA | 2000年 / 9卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Anxiety disorders in children and adolescents can be considered a silent epidemic. Their prevalence in this population has been reported to range between 6% and 18%. The pharmacologic treatment of these disorders is reviewed in this article. Studies regarding the use of tricyclic antidepressants, benzodiazepines, buspirone, and selective serotonin reuptake inhibitors (SSRIs) and clinical considerations for the use of these medications are discussed. SSRIs seem to be the most efficacious and safe agents for the pharmacologic treatment of pediatric anxiety disorders. This article emphasizes the need for additional studies.
引用
收藏
页码：119 / +
页数：16
相关论文
共 50 条
  • [31] Current Approaches to the Pharmacologic Treatment of Anxiety Disorders
    Sheehan, David V.
    Sheehan, Kathy Harnett
    PSYCHOPHARMACOLOGY BULLETIN, 2007, 40 (01) : 98 - 109
  • [32] The Pharmacologic Treatment of Anxiety Disorders: A Review of Progress
    Ravindran, Lakshmi N.
    Stein, Murray B.
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (07) : 839 - 854
  • [33] Spectrum of Anxiety Disorders: Diagnosis and Pharmacologic Treatment
    Karsnitz, Deborah Brandt
    Ward, Sheila
    JOURNAL OF MIDWIFERY & WOMENS HEALTH, 2011, 56 (03) : 266 - 281
  • [34] Open fluoxetine treatment of mixed anxiety disorders in children and adolescents
    Fairbanks, JM
    Pine, DS
    Tancer, NK
    Dummit, ES
    Kentgen, LM
    Martin, J
    Asche, BK
    Klein, RG
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 1997, 7 (01) : 17 - 29
  • [35] The influence of comorbidity on treatment outcome for children and adolescents with anxiety disorders
    Rapee, RM
    BEHAVIOUR RESEARCH AND THERAPY, 2003, 41 (01) : 105 - 112
  • [36] Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders
    不详
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2007, 46 (02): : 267 - 283
  • [37] An overview of controlled studies of anxiety disorders treatment in children and adolescents
    Scott, RW
    Mughelli, K
    Deas, D
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2005, 97 (01) : 13 - 24
  • [38] Fluvoxamine for the treatment of anxiety disorders in children and adolescents. Reply
    Pine, DS
    Walkup, JT
    Greenhill, L
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (06): : 466 - 467
  • [39] Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders
    Bernstein, GA
    Shaw, K
    Dunne, JE
    Ayres, W
    Arnold, V
    Benedek, E
    Benson, RS
    Bernet, W
    Bryant, E
    Gross, RL
    Jaffe, S
    King, R
    Kinlan, J
    Leonard, H
    Licamele, W
    McClellan, J
    Zametkin, A
    Sloan, LE
    Miles, CM
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1997, 36 (10): : S69 - S84
  • [40] Pharmacological treatment of anxiety disorders in children and adolescents: a review for practitioners
    Patel, Dilip R.
    Feucht, Cynthia
    Brown, Kelly
    Ramsay, Jessica
    TRANSLATIONAL PEDIATRICS, 2018, 7 (01) : 23 - 35
12345